Peiliang Shen
Overview
Explore the profile of Peiliang Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao Y, Tao Y, Li G, Shen P, Pellenq R, Poon C
Proc Natl Acad Sci U S A
. 2025 Jan;
122(1):e2418239121.
PMID: 39793077
CO mineralization, a process where CO reacts with minerals to form stable carbonates, presents a sustainable approach for CO sequestration and mitigation of global warming. While the crucial role of...
2.
Li G, Tao Y, Zhu X, Gao Y, Shen P, Yin B, et al.
Nat Commun
. 2024 Dec;
15(1):10790.
PMID: 39738086
The feasibility of carbon mineralization relies on the carbonation efficiency of CO-reactive minerals, which is largely governed by the water content and state within material mesopores. Yet, the pivotal role...
3.
Jiang L, Ma Z, Gu Z, Shen P, Tao Y, Li W, et al.
Adv Mater
. 2024 Aug;
36(40):e2405492.
PMID: 39177200
Superhydrophobic surfaces applying on concrete can greatly improve the durability of concrete by preventing the damage from water. However, traditional design of superhydrophobic concrete surfaces by external coating encounters to...
4.
Jia Y, Yao Y, Fan L, Huang Q, Wei G, Shen P, et al.
J Nanobiotechnology
. 2024 Jun;
22(1):346.
PMID: 38898493
Chemoresistance remains a significant challenge for effective breast cancer treatment which leads to cancer recurrence. CRISPR-directed gene editing becomes a powerful tool to reduce chemoresistance by reprogramming the tumor microenvironment....
5.
Zhou W, Zhu C, Shen P, Wang J, Zhu G, Jia Y, et al.
iScience
. 2024 Apr;
27(5):109547.
PMID: 38660400
Circulating tumor cell clusters/micro-emboli (CTM) possess greater metastatic capacity and survival advantage compared to individual circulating tumor cell (CTC). However, the formation of CTM subtypes and their role in tumor...
6.
Shen P, Cheng P, Li Y, Zong G, Deng R, Qian C, et al.
Eur J Pharmacol
. 2023 Nov;
962:176217.
PMID: 38036200
The formation of the microenvironment preceding liver metastasis is intricately linked to the intestinal tract. In recent years, mounting evidence has revealed the significant involvement of neutrophil extracellular traps (NETs)...
7.
Shen P, Jia Y, Zhou W, Zheng W, Wu Y, Qu S, et al.
Acta Pharm Sin B
. 2023 Nov;
13(11):4621-4637.
PMID: 37969730
Hepatic stellate cells (HSCs) represent a significant component of hepatocellular carcinoma (HCC) microenvironments which play a critical role in tumor progression and drug resistance. Tumor-on-a-chip technology has provided a powerful...
8.
Zheng W, Shen P, Yu C, Tang Y, Qian C, Yang C, et al.
Pharmacol Res
. 2023 Nov;
198:106986.
PMID: 37944834
Tumor cell extravasation across endothelial barrier has been recognized as a pivotal event in orchestrating metastasis formation. This event is initiated by the interactions of extravasating tumor cells with endothelial...
9.
Jia Y, Sun J, Yang J, Chen C, Zhang Z, Yang K, et al.
ACS Appl Mater Interfaces
. 2023 Mar;
15(13):16329-16342.
PMID: 36946515
Multidrug resistance in cancer stem cells (CSCs) is a major barrier to chemotherapy; hence, developing CSC-specific targeted nanocarriers for efficient drug delivery is critical. In this study, monodisperse hollow-structured MnO...
10.
Zheng W, Qian C, Tang Y, Yang C, Zhou Y, Shen P, et al.
Front Immunol
. 2022 Nov;
13:1035323.
PMID: 36439137
Immunotherapy has been recognized as an effective and important therapeutic modality for multiple types of cancer. Nevertheless, it has been increasing recognized that clinical benefits of immunotherapy are less than...